Atlas Trials

Bioequivalence Study of Two Formulations of Tablets Ramipril/Hydrochlorothiazide 10 mg/25 mg in Healthy Volunteers Under Fasting Conditions

Clinical trial NCT05685277 · COMPLETED

Trial details

NCT number
NCT05685277
Sponsor
Pharmtechnology LLC
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Bioequivalence
Start date
2022-12-28
Primary completion
2023-02-22
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.